Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
EOLS on Nasdaq
Shares outstanding
64,670,984
Price per share
$6.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
54,269,227
Total reported value
$333,225,539
% of total 13F portfolios
0%
Share change
-4,056,421
Value change
-$49,044,182
Number of holders
158
Price from insider filings
$6.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 8.8% +49% $35,162,902 +$12,129,656 5,726,857 +53% Nantahala Capital Management, LLC 30 Sep 2025
LYNCH TIMOTHY P 7.9% +27% $31,521,385 +$6,381,222 5,133,776 +25% Timothy P. Lynch 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC 7.9% $58,219,698 4,997,399 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
BlackRock, Inc. 6.9% $50,851,038 4,364,896 BlackRock, Inc. 31 Dec 2024
Caligan Partners LP 6.4% +24% $25,413,110 +$4,893,414 4,138,943 +24% Caligan Partners LP 30 Sep 2025
PERCEPTIVE ADVISORS LLC 3.8% -43% $23,461,512 -$15,682,755 2,474,843 -40% Perceptive Advisors LLC 30 Jun 2025
Medytox Inc. 3.4% $24,889,631 2,136,449 Medytox Inc. 31 Dec 2024

As of 30 Sep 2025, 158 institutional investors reported holding 54,269,227 shares of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS). This represents 84% of the company’s total 64,670,984 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 8.9% 5,726,857 +36% 2.2% $35,162,902
TANG CAPITAL MANAGEMENT LLC 8.5% 5,488,299 +9.8% 1.3% $33,698,156
BlackRock, Inc. 6.9% 4,476,691 +7% 0% $27,486,880
Caligan Partners LP 6.4% 4,138,943 +24% 3.5% $25,413,110
VANGUARD GROUP INC 5.3% 3,428,943 +3.3% 0% $21,053,710
Frazier Life Sciences Management, L.P. 4.1% 2,630,665 +8% 0.48% $16,152,283
MILLENNIUM MANAGEMENT LLC 2.9% 1,859,003 +25% 0.01% $11,414,278
Stonepine Capital Management, LLC 2.4% 1,536,391 +68% 7.7% $9,433,441
STATE STREET CORP 2.3% 1,515,217 +7.7% 0% $9,303,432
Eversept Partners, LP 2.3% 1,475,109 +26% 0.69% $9,057,169
Soleus Capital Management, L.P. 2.2% 1,450,000 -32% 0.48% $8,903,000
GEODE CAPITAL MANAGEMENT, LLC 2.2% 1,417,192 +15% 0% $8,702,787
D. E. Shaw & Co., Inc. 2.1% 1,354,395 +41% 0.01% $8,315,986
RICE HALL JAMES & ASSOCIATES, LLC 1.8% 1,168,886 +17% 0.39% $7,176,960
Nuveen, LLC 1.7% 1,071,367 +20% 0% $6,578,193
UBS Group AG 1.6% 1,030,116 -4.3% 0% $6,324,913
BOOTHBAY FUND MANAGEMENT, LLC 1.6% 1,029,701 -12% 0.16% $6,322,364
SCHRODER INVESTMENT MANAGEMENT GROUP 1.6% 1,014,473 -4% 0% $6,228,864
PINNACLE ASSOCIATES LTD 1% 674,875 -1.6% 0.05% $4,143,733
RENAISSANCE TECHNOLOGIES LLC 0.97% 626,000 +83% 0.01% $3,843,640
AWH Capital, L.P. 0.97% 625,000 0% 4% $3,837,500
CITADEL ADVISORS LLC 0.91% 588,409 +1.1% 0% $3,612,831
NORTHERN TRUST CORP 0.85% 552,410 +11% 0% $3,391,798
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 490,303 +17% 0% $3,010,460
GOLDMAN SACHS GROUP INC 0.71% 457,697 +54% 0% $2,810,260

Institutional Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 318,766 $2,115,640 +$170,362 $6.65 10
2025 Q3 54,269,227 $333,225,539 -$49,044,182 $6.14 158
2025 Q2 58,306,002 $536,933,982 +$27,282,114 $9.21 171
2025 Q1 54,269,937 $652,886,328 +$25,547,799 $12.03 178
2024 Q4 51,921,808 $573,114,520 +$6,665,899 $11.04 164
2024 Q3 50,293,278 $814,501,081 -$14,779,328 $16.20 164
2024 Q2 51,340,763 $557,051,494 +$21,839,886 $10.85 155
2024 Q1 49,347,816 $690,868,493 +$53,544,087 $14.00 160
2023 Q4 45,541,929 $479,552,344 +$47,465,780 $10.53 149
2023 Q3 41,447,331 $378,821,815 +$40,085,326 $9.14 135
2023 Q2 37,278,540 $271,085,912 +$16,634,153 $7.27 132
2023 Q1 34,126,762 $288,714,148 +$41,941,872 $8.46 124
2022 Q4 29,273,655 $219,845,469 +$14,363,180 $7.51 116
2022 Q3 25,565,680 $205,795,765 -$5,087,386 $8.05 122
2022 Q2 25,348,901 $294,043,424 +$27,306,633 $11.60 117
2022 Q1 23,065,245 $258,202,339 +$27,115,832 $11.22 115
2021 Q4 20,576,998 $133,137,102 +$16,160,367 $6.51 102
2021 Q3 17,623,312 $134,773,188 +$2,126,205 $7.62 109
2021 Q2 16,226,875 $205,283,641 +$96,350,898 $12.65 111
2021 Q1 8,608,655 $111,825,892 +$19,807,970 $12.99 92
2020 Q4 7,776,423 $26,127,429 +$1,508,358 $3.36 79
2020 Q3 7,265,841 $28,771,905 -$11,631,486 $3.91 77
2020 Q2 9,284,051 $49,207,493 -$20,294,810 $5.30 80
2020 Q1 14,269,284 $58,934,912 -$12,174,946 $4.15 95
2019 Q4 13,995,058 $170,310,558 +$99,390,874 $12.17 101
2019 Q3 5,663,928 $88,460,159 +$6,453,980 $15.62 92
2019 Q2 5,294,303 $77,402,817 +$17,407,129 $14.62 103
2019 Q1 3,901,128 $88,035,182 -$2,688,589 $22.57 90
2018 Q4 5,405,565 $64,325,153 -$25,490,499 $11.90 72
2018 Q3 6,656,409 $123,935,961 +$57,861,875 $18.62 68
2018 Q2 3,521,598 $98,567,769 +$802,066 $27.99 54
2018 Q1 4,445,338 $40,139,664 +$40,139,664 $9.03 39
2016 Q2 0 $0 -$286,000 $6.65 0
2016 Q1 12,761 $286,000 $22.41 1